Drugs developed to improve erectile dysfunction have improved sexual function and activity in 80% of users, but did not translate into satisfaction with sex and relationships for older men, a study has found.
The European Medicines Agency has recommended granting a marketing authorisation for new melanoma treatment nivolumab.
Scientists have developed a therapy that could outsmart cancer cells that have become immune to certain treatments, according to a study published in Cancer Cell.
What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.
Interferon beta and glatiramer acetate are cost-effective treatments for multiple sclerosisSubscription
Interferon beta and glatiramer acetate each reduce disability progression by 24-40% in patients with relapsing-remitting multiple sclerosis, according to a study published in The Lancet Neurology.
A new prescription analysis system for community pharmacists in the UK has been launched by the Pharmaceutical Services Negotiating Committee and the National Pharmacy Association.
Oral insulin powder was given to children with a high genetic risk of developing type 1 diabetes, as part of a phase I clinical trial, which researchers claim brings them a step closer to a vaccine.
The General Pharmaceutical Council has issued guidance on the provision of non-traditional services when patients may not have face-to-face contact with a pharmacist.
Mindfulness-based cognitive therapy offers an alternative to maintenance antidepressant medication but is not superior, according to new research.
Women are now able to buy the emergency contraceptive ellaOne (ulipristal acetate, 30mg) from UK pharmacies without a prescription, its manufacturer has confirmed.
Researchers have developed a new biochip platform that will help to make drug discovery quicker and more cost-effective, according to an article published in Scientific Reports.
Researchers have shown that compared with placebo paracetamol blunts emotional responses to both unpleasant and pleasant images.
Incentives are needed to encourage the development of new medicines to tackle diseases that disproportionately affect the poor, says the World Health Organization.
A potent type of antibody therapy trialled in HIV patients for the first time has been shown to reduce the amount of virus in patients’ blood.
Safeguarding patients against the risk of bleeding is a vital role for pharmacists when dealing with patients taking new oral anticoagulants.
Adherence to the oral anticoagulant dabigatran varies substantially among clinics and is higher at sites with pharmacist-led monitoring and appropriate patient selection, a US study has found.
Holistic service from community pharmacists can reduce fall risk and improve patients’ quality of lifeSubscription
A holistic, community pharmacy-based medicines review service directed at older patients taking four or more medicines can improve quality of life, medicines adherence and reduce the risk of falls, suggests new research.
Identification and characterisation of a small molecule that targets protein receptors that stimulate the immune system could lead to novel vaccine adjuvants and anti-tumour agents.
The US Food and Drug Administration has granted a licence for the heart failure medication ivabradine, ten years after the drug was first approved in Europe.
The European Medicines Agency has launched a consultation on proposals to improve the prevention, reporting and evaluation of medication errors.
For patients with neuropathic pain, average daily pain scores were reduced significantly more with combination therapy than with either nortriptyline or morphine alone.
Treatment with cannabidiol reduces seizure frequency for patients with certain epilepsy conditions, research suggests.
Study reveals that 5.8% of primary school children (10–11 years) and 12.3% of secondary school children (11–16 years) have used e-cigarettes.
The anti-cancer agent imatinib at very low doses mimics a physiological innate response to infection in the bone marrow, research shows.
A major research venture has yielded two antibiotic regimens for treating severe infections that can be administered in the outpatient setting.
Xylitol may not protect teeth from decaySubscription
Cochrane reviewers have found little or no good-quality evidence to prove xylitol has a protective effect against tooth decay.
Trials of antidepressants used to treat anxiety disorders that the US Food and Drug Administration deemed positive were more likely to be published than those deemed negative.
In a survey of customers at five community pharmacies in Australia, 10.6% of respondents admitted to modifying their medication.